Related Experiment Video
Updated: Jun 24, 2025

05:37
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
12.1K
Sexually Dimorphic Response to Hepatic Injury in Newborn Suffering from Intrauterine Growth Restriction
Yu-Sen Wei1, Wen-Jie Tang1, Pei-Yu Mao2
1College of Animal Science, Zhejiang University, The Key Laboratory of Molecular Animal Nutrition, Ministry of Education, Hangzhou, 310000, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|June 13, 2024
Summary
Intrauterine growth restriction (IUGR) causes liver injury, with females showing better regeneration via immune adaptation. Males experience severe damage, but APOA4 and PPARα activation offer potential therapeutic avenues for IUGR liver disease.
Area of Science:
- Developmental biology
- Hepatology
- Immunology
Background:
- Intrauterine growth restriction (IUGR) impairs fetal development, leading to reduced liver function and increased chronic liver disease risk.
- Early life plasticity offers a potential window to reverse adverse fetal programming outcomes.
- Sex-specific responses to IUGR-induced liver injury are not well understood.
Purpose of the Study:
- To investigate the sex-specific cellular and molecular mechanisms of liver injury and regeneration in a piglet model of IUGR.
- To identify potential therapeutic targets for mitigating IUGR-related hepatic damage.
Main Methods:
- scRNA-seq analysis of liver tissue from IUGR and control piglets.
- Biochemical profiling and assessment of hypoxic stress response.
- Investigation of Apolipoprotein A4 (APOA4) and PPARα activation.
Main Results:
- IUGR piglets exhibited sex-dependent hepatic injury patterns.
- IUGR females displayed fibroblast-driven T cell reprogramming, promoting inflammation resolution and liver regeneration.
- IUGR males showed exacerbated liver injury, impaired regeneration due to inflammation and disrupted lipid metabolism, with elevated APOA4.
Conclusions:
- Hepatic injury and regeneration in IUGR are sexually dimorphic, with distinct immune and metabolic responses.
- APOA4 may serve as a biomarker, and PPARα activation shows therapeutic potential for IUGR males.
- Understanding these sex differences is crucial for developing targeted interventions for IUGR-associated liver disease.

